Article | May 20, 2016

Quality By Design In Biopharma R&D: Bringing Quality Forward Pays Off

Source: Dassault Systemes Americas

By Tim Moran, Product Manager, Life Science Research, Dassault Systèmes BIOVIA


With biologics filling the pipelines of life sciences companies more than ever, the biopharmaceutical industry needs to rethink its view of quality. Once primarily considered a focus in downstream drug development and manufacturing, quality now demands just as much attention in upstream discovery research.

The need to focus on quality during early biologics research stems in part from the complexity of biologics, but it also results from the increased regulatory scrutiny required when working with living organisms as source materials from early research through production of biologics.